BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 26142830)

  • 21. The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems.
    Tanabe M; Tokuda Y; Takasu K; Ono K; Honda M; Ono H
    Br J Pharmacol; 2007 Feb; 150(4):403-14. PubMed ID: 17220907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GABA-A receptor activity in the noradrenergic locus coeruleus drives trigeminal neuropathic pain in the rat; contribution of NAα1 receptors in the medial prefrontal cortex.
    Kaushal R; Taylor BK; Jamal AB; Zhang L; Ma F; Donahue R; Westlund KN
    Neuroscience; 2016 Oct; 334():148-159. PubMed ID: 27520081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous and Intratracheal Thyrotropin Releasing Hormone and Its Analog Taltirelin Reverse Opioid-Induced Respiratory Depression in Isoflurane Anesthetized Rats.
    Boghosian JD; Luethy A; Cotten JF
    J Pharmacol Exp Ther; 2018 Jul; 366(1):105-112. PubMed ID: 29674333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models.
    Kelly JA; Boyle NT; Cole N; Slator GR; Colivicchi MA; Stefanini C; Gobbo OL; Scalabrino GA; Ryan SM; Elamin M; Walsh C; Vajda A; Goggin MM; Campbell M; Mash DC; O'Mara SM; Brayden DJ; Callanan JJ; Tipton KF; Della Corte L; Hunter J; O'Boyle KM; Williams CH; Hardiman O
    Neuropharmacology; 2015 Feb; 89():193-203. PubMed ID: 25281210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral nerve injury and gabapentin, but not their combination, impair attentional behavior via direct effects on noradrenergic signaling in the brain.
    Suto T; Eisenach JC; Hayashida K
    Pain; 2014 Oct; 155(10):1935-42. PubMed ID: 24837843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats.
    Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K
    Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Taltirelin, a thyrotropin-releasing hormone analog, alleviates mechanical allodynia through activation of descending monoaminergic neurons in persistent inflammatory pain.
    Eto K; Kim SK; Nabekura J; Ishibashi H
    Brain Res; 2011 Sep; 1414():50-7. PubMed ID: 21872219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormone.
    Scalabrino GA; Hogan N; O'Boyle KM; Slator GR; Gregg DJ; Fitchett CM; Draper SM; Bennett GW; Hinkle PM; Bauer K; Williams CH; Tipton KF; Kelly JA
    Neuropharmacology; 2007 Jun; 52(7):1472-81. PubMed ID: 17418282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel thyrotropin-releasing hormone analogs: a patent review.
    Khomane KS; Meena CL; Jain R; Bansal AK
    Expert Opin Ther Pat; 2011 Nov; 21(11):1673-91. PubMed ID: 22017410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective effect and brain receptor binding of taltirelin, a novel thyrotropin-releasing hormone (TRH) analogue, in transient forebrain ischemia of C57BL/6J mice.
    Urayama A; Yamada S; Kimura R; Zhang J; Watanabe Y
    Life Sci; 2002 Dec; 72(4-5):601-7. PubMed ID: 12467901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excitation of histaminergic tuberomamillary neurons by thyrotropin-releasing hormone.
    Parmentier R; Kolbaev S; Klyuch BP; Vandael D; Lin JS; Selbach O; Haas HL; Sergeeva OA
    J Neurosci; 2009 Apr; 29(14):4471-83. PubMed ID: 19357273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel TRH analog, Glp-Asn-Pro-D-Tyr-D-TrpNH2, binds to [3H][3-Me-His2]TRH-labelled sites in rat hippocampus and cortex but not pituitary or heterologous cells expressing TRHR1 or TRHR2.
    Hogan N; O'Boyle KM; Hinkle PM; Kelly JA
    Neurosci Lett; 2008 Jan; 431(1):26-30. PubMed ID: 18069127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained impairment of α2A-adrenergic autoreceptor signaling mediates neurochemical and behavioral sensitization to amphetamine.
    Doucet EL; Bobadilla AC; Houades V; Lanteri C; Godeheu G; Lanfumey L; Sara SJ; Tassin JP
    Biol Psychiatry; 2013 Jul; 74(2):90-8. PubMed ID: 23332355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of effects of hypotension and handling stress on the release of noradrenaline and dopamine in the locus coeruleus and medial prefrontal cortex of the rat.
    Kawahara Y; Kawahara H; Westerink BH
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jul; 360(1):42-9. PubMed ID: 10463333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin 5-HT
    Perez-Palomar B; Mollinedo-Gajate I; Berrocoso E; Meana JJ; Ortega JE
    Neuropharmacology; 2018 May; 133():491-502. PubMed ID: 29477299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyrotropin-releasing hormone receptor type 1 (TRH-R1), not TRH-R2, primarily mediates taltirelin actions in the CNS of mice.
    Thirunarayanan N; Nir EA; Raaka BM; Gershengorn MC
    Neuropsychopharmacology; 2013 May; 38(6):950-6. PubMed ID: 23303050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of repeated cocaine administration on the thyrotropin-releasing hormone level and receptors in the rat brain.
    Jaworska-Feil L; Budziszewska B; Lasoń W
    Neuropeptides; 1997 Jun; 31(3):253-8. PubMed ID: 9243522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction to Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{
    Kobayashi N; Sato N; Fujimura Y; Kihara T; Sugita K; Takahashi K; Koike K; Sugawara T; Tada Y; Nakai H; Yoshikawa T
    ACS Omega; 2019 Apr; 4(4):6977-6978. PubMed ID: 31459810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clozapine- and olanzapine-induced Fos expression in the rat medial prefrontal cortex is mediated by beta-adrenoceptors.
    Ohashi K; Hamamura T; Lee Y; Fujiwara Y; Suzuki H; Kuroda S
    Neuropsychopharmacology; 2000 Aug; 23(2):162-9. PubMed ID: 10882842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Centrally acting and metabolically stable thyrotropin-releasing hormone analogues by replacement of histidine with substituted pyridinium.
    Prokai L; Prokai-Tatrai K; Zharikova AD; Nguyen V; Perjesi P; Stevens SM
    J Med Chem; 2004 Nov; 47(24):6025-33. PubMed ID: 15537357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.